Arsenic exposure was associated with promoter methylation of RASSF1A (P < 0.02) and PRSS3 (P < 0.1), but not of p16 (INK4A) or SFRP, in human bladder tumor samples adjusted for stage and other risk factors. The gene discussed is CDKN2A; the disease is urinary bladder neoplasm.